Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377)
01/2005
01/18/2005CA2203553C Process for the manufacture of n-phosphonomethylglycine
01/13/2005WO2005003777A2 Enzyme-catalyzed metal deposition for the enhanced in situ detection of immunohistochemical epitopes and nucleic acid sequences
01/13/2005WO2005003143A1 Novel potassium channel modulators
01/13/2005WO2005003077A1 Method for producing difluoro-acetyl-acetic acid alkylesters
01/13/2005WO2005002626A2 Therapeutic phosphonate compounds
01/13/2005WO2004099134A3 Glutaminyl based dp iv-inhibitors
01/13/2005WO2004094658A3 Fluorescent substrates for detecting organophosphatase enzyme activity
01/13/2005US20050010060 Novel quinones as disease therapies
01/13/2005US20050010054 Preparation of crystalline polymorphs of fosinopril sodium
01/13/2005US20050010038 Chelants and macrocyclic metal complex radiopharmaceuticals thereof
01/13/2005US20050009967 Reacting a neoalkyl chlorophosphite directly with a sterically hindered mono- or di-substituted hydroxylated aromatic compound to produce a product having little or no odor; polymer additives to provide heat and hydrolytic stability
01/13/2005US20050009930 Carotenoid analogs or derivatives for controlling connexin 43 expression
01/13/2005US20050009844 Inhibitors of p38
01/13/2005US20050009842 2-hydroxymethylcyclopropylidene methylpurines and -pyrimidines as antiviral agents
01/13/2005US20050009816 Potassium channel modulators
01/13/2005US20050009788 The analog includes a conjugated polyene with 7 to 14 double bonds and a 3,3-dimethylcyclohexenylene or 3,3-dimethylcyclohexen-6-onylene ring; especially for treating cardiac arrhythmia and cancerous and pre-cancerous cells
01/13/2005US20050009786 Immunosuppressant compounds and compositions
01/13/2005US20050009758 Therapy for ischemic-repefusion injuries; liver disorders; antiarrhythmia agents; anticancer agents; astaxanthin
01/13/2005US20050009043 Prodrugs of phosphonate nucleotide analogues
01/13/2005US20050008575 Chelants and macrocyclic metal complex radiopharmaceuticals thereof
01/13/2005DE10324568A1 Styrol-Hypophosphit-Addukt sowie ein Verfahren zu dessen Herstellung und seine Verwendung The styrene-hypophosphite adduct as well as a process for its preparation and its use
01/13/2005DE10297577T5 Zinkkomplexe, die fähig sind, Substanzen, die anionische Substituenten haben, abzufangen Zinc complexes, which are capable of substances having anionic substituents trap,
01/13/2005CA2773566A1 Enzyme-catalyzed metal deposition for the enhanced in situ detection of immunohistochemical epitopes and nucleic acid sequences
01/12/2005EP1496063A1 Novel phosphonamides, process for producing the same, and use thereof
01/12/2005EP1495129A2 Hybrid phosphoinositide phospholipids: compositions and uses
01/12/2005EP1495037A1 Method for the production of perfluoroalkyl phosphines and the use thereof as perfluoroalkylating reactants
01/12/2005EP1495036A1 Method for the production of monohydro-perfluoroalkanes, bis(perfluoroalkyl)phosphinates, and perfluoroalkylphosphonates
01/12/2005EP1495035A1 Method for the production of bis(perfluoroalkyl)phosphinic acids and the salts thereof
01/12/2005EP1495034A2 Mimics of acyl coenzyme-a comprising pantolactone and pantothenic acid derivatives, compositions thereof, and methods of cholesterol management and related uses
01/12/2005EP1494988A1 A method of making salt
01/12/2005EP1494982A1 Method for perfluoroalkylation by means of tris(perfluoroalkyl)phosphine oxides
01/12/2005EP1419194B1 Phosphorus compounds as stabilizers
01/12/2005EP1224505B1 Electrochromic device
01/12/2005EP1176937B1 Self-adhesive polymerizable monomer and dental/medical compositions therefrom
01/12/2005CN1564825A 二膦 Diphosphonic
01/12/2005CN1564824A Ligands for asymmetric reactions
01/12/2005CN1564823A High boiling inhibitors for distillable, polymerizable monomers
01/12/2005CN1564815A Halogen-free flame retardant compounds
01/12/2005CN1563022A Method of oxidizing N-phosphonometyl to prepare glyphosate
01/12/2005CN1563021A Preparation technique for synthesizing glyphosate through dehydrogenation oxidation process for diethanolamine
01/12/2005CN1563020A Chirality phosphine ligand, synthesis, and application in asymmetric catalyfic reaction
01/12/2005CN1563019A Method of technique of ion exchange for extracting phytic acid
01/12/2005CN1563018A Extracting high precision medical use lecithin from fat liver of goose through high new bioseparation technique
01/12/2005CN1563017A Technique of neutralizing methyl alcohol in production of 0.0-dimethyl thiophosphoryl chloride
01/12/2005CN1562926A New type spirocyclic diphosphine ligand, and application in asymmetric catalytic hydrogenation
01/12/2005CN1561990A Treatment of immune diseases
01/12/2005CN1184225C Tetraphosphine quatorphosphonium salt, its preparing process, and two-step tetraphosphine medicine kit and its application
01/12/2005CN1184224C Fluoro-alkyl lithium phosphate, and application as electrolytic salt
01/12/2005CN1184219C Taxusane phoshponic oxygen methyl ether derivant
01/11/2005US6841698 Aminopropylphosphinic acids
01/11/2005US6841638 Ionic compounds with delocalized anionic charge, and their use as ion conducting components or as catalysts
01/11/2005US6841598 Antistatic and antidust agents, compositions thereof, and methods of manufacture
01/11/2005US6841559 Prevention or inhibition of normal pilus assembly in Gram-negative bacterium impacts the pathogenicity of the bacterium
01/11/2005US6841502 For catalytic polymerization of ethylene/olefin copolymers
01/11/2005US6841304 Dissolves other salts, in particular metallic salts, such as lithium salts, to give highly conductive solutions
01/11/2005US6841301 Batteries, capacitors
01/11/2005US6841086 Aqueous composition of alkali metal salts of partial alkyl esters of phosphoric acid, method for stabilization and a fiber finish
01/11/2005US6840469 Process for coating particulates with phosphated castor oil
01/11/2005CA2118496C Method of reducing microorganism adhesion
01/11/2005CA2104909C Decahydroisoquinolines as excitatory amino acid receptor antagonists
01/06/2005WO2005002007A2 Process for producing semiconductor nanocrystal cores, core-shell, core-buffer-shell, and multiple layer systems in a non-coordinating solvent utilizing in situ surfactant generation
01/06/2005WO2005001030A2 Markers for pre-cancer and cancer cells and the method to interfere with cell proliferation therein
01/06/2005WO2005000994A2 Epoxy-stabilized polyphosphate compositions
01/06/2005WO2005000859A2 Novel reagent compounds and methods of making and using the same
01/06/2005WO2005000858A2 Bisphosphonate complexes
01/06/2005WO2005000833A1 Immunosuppressant compounds and compositions
01/06/2005WO2005000777A2 Process for the preparation of cinnamaldehyde compounds
01/06/2005WO2004106486A3 Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders
01/06/2005WO2004103977A3 Process for the preparation of pyrimidine derivatives
01/06/2005WO2004082604A3 Phosphoric ester demulsifier composition
01/06/2005WO2004065396A3 Phosphoric esters of polyisobutene-substituted aromatic hydroxy compounds
01/06/2005WO2004058402A8 Process for the recovery of phosphorus and iodine containing catalyst components
01/06/2005WO2004026454A3 Formation of enediynes by reductive coupling followed by alkyne metathesis
01/06/2005US20050004356 Linker nucleoside, its preparation and use
01/06/2005US20050004247 Contains less volatile decomposition products and by products than known acyl- and bis-acylphosphine oxides; photoinitiators
01/06/2005US20050004235 Carotenoid analogs or derivatives for the inhibition and amelioration of liver disease
01/06/2005US20050004174 Antibacterial agents
01/06/2005US20050004169 4-O alkanoic esters; cancer; type II DNA topoisomerase inhibition, enzyme mediated production of lethal DNA strand breaks
01/06/2005US20050004152 Thiazole compounds useful as inhibitors of protein kinase
01/06/2005US20050004083 such as 3-(aminocyclopentanyl)butylphosphinic acid ; GABA (gamma-amino-butyric acid) receptor agonists/antagonists; for memory enhancement
01/06/2005US20050004082 Ether compounds
01/06/2005US20050004080 Brain disorders; antiischemic agents; antiepileptic agents; cardiovascular disorders; vision defects; spinal cord injuries; psychological disorders; anxiolytic agents; schizophrenia
01/06/2005US20050004077 Antidiabetic agents ; bioavailability
01/06/2005US20050003085 Composition for forming a coating film, method of preparing the composition, tantalum oxide film and method of forming the tantalum oxide film
01/06/2005US20050000824 Batteries, capacitors; electrolytic cells
01/06/2005CA2530279A1 Bisphosphonate complexes
01/06/2005CA2530111A1 Glycogen synthase kinase-3 inhibitors
01/06/2005CA2529086A1 Process for the preparation of cinnamaldehyde compounds
01/06/2005CA2526639A1 Chimeric rnas and their use for cancer diagonostics and therapy
01/06/2005CA2524048A1 Immunosuppressant compounds and compositions
01/05/2005EP1492800A2 Process for manufacturing purified phosphorodiamidite
01/05/2005EP1492776A2 Iodinated triglyceride analogs
01/05/2005EP1492526A2 Improved prodrugs of cc-1065 analogs
01/05/2005EP1492502A1 Novel polymorphs and pseudopolymorphs of risedronate sodium
01/05/2005EP1366053B1 Flame-proofing agents
01/05/2005EP1027349B1 Tetrahydrofuran phosphate- and hydroxy esters, as prodrugs for the corresponding antifungal agent
01/05/2005CN1561525A Proton conductor and method for manufacturing the same, and electrochemical device
01/05/2005CN1561333A Aromatic and heteroaromatic acid halides for synthesizing polyamides
01/05/2005CN1561327A Novel aminobenzoephenones
01/05/2005CN1561326A Alpha-haloenamine reagents